Epitranscriptomic challenges and promises in metabolic diseases

Metabolism. 2022 Jul:132:155219. doi: 10.1016/j.metabol.2022.155219. Epub 2022 May 18.
No abstract available

Keywords: Cardiovascular disease; Diabetes; Epigenetics; NAFLD; Obesity; Transcriptomics.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Metabolic Diseases* / therapy
  • Metabolic Syndrome* / metabolism
  • Non-alcoholic Fatty Liver Disease* / metabolism
  • Risk Factors